ReviewFrontiers in immunology2026

The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune tolerance.

Ziyue Sha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.